Brief: CK Life Sciences says HY profit attributable to shareholders down 9%
July 17 (Reuters) - Ck Life Sciences Intl (Holdings) Inc
0775.HK
* For six months ended 30 June 2017, unaudited profit
attributable to shareholders HK$170 million, down 9%
* HY revenue HK$2.31 billion versus HK$2.53 billion
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3tXBkV
Further company coverage: 0775.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development